Braxia Scientific Corp.
BRAXF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 26.7% | 47.5% | 475,547.2% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 9.1% | -220.7% | -286.7% | -4,219.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -674.2% | -479.9% | -8,806.8% | -1,555,754.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -697.5% | -815.9% | -8,809.1% | -81,473.1% |
| EPS Diluted | -0.058 | -0.069 | -0.56 | -0.004 |
| % Growth | 16.9% | 87.6% | -12,627.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |